PF-06647020 (PF-7020), an antibody-drug conjugate (ADC) targeting protein tyrosine kinase 7 (PTK7), in patients (pts) with advanced solid tumors: Results of a phase I dose escalation and expansion study.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.5565
Abstract: 5565Background: PF-7020 is an ADC comprising of a humanized monoclonal antibody against PTK7, a cleavable valine-citrulline linker and auristatin payload that is being investigated in an ongoing Ph... read more here.
Keywords: adc; 7020 antibody; antibody; 06647020 7020 ... See more keywords